[Hemorheological tests in subjects with vascular diseases and post-infarction patients treated with platelet aggregation inhibitors].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001809:Blood Viscosity / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000097:blood* / Q000188:drug therapy; D004913:Erythrocytes, Abnormal / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects*; D011379:Prognosis; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents
Tests emoreologici nei soggetti vasculopatici e nei post-infartuati trattati con antiaggreganti piastrinici.